Susquehanna Fundamental Investments’s Revance Therapeutics, Inc. RVNC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-551,224
Closed -$1.68M 1262
2024
Q4
$1.68M Buy
+551,224
New +$1.68M 0.02% 574